Elias Kouchakji

2020

In 2020, Elias Kouchakji earned a total compensation of $2.9M as Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance at FibroGen, a 42% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$259,065
Option Awards$1,001,625
Salary$570,000
Stock Awards$990,375
Other$64,215
Total$2,885,280

Kouchakji received $1M in option awards, accounting for 35% of the total pay in 2020.

Kouchakji also received $259.1K in non-equity incentive plan, $570K in salary, $990.4K in stock awards and $64.2K in other compensation.

Rankings

In 2020, Elias Kouchakji's compensation ranked 4,011th out of 13,090 executives tracked by ExecPay. In other words, Kouchakji earned more than 69.4% of executives.

ClassificationRankingPercentile
All
4,011
out of 13,090
69th
Division
Manufacturing
1,616
out of 5,621
71st
Major group
Chemicals And Allied Products
616
out of 2,254
73rd
Industry group
Drugs
532
out of 1,954
73rd
Industry
Pharmaceutical Preparations
406
out of 1,459
72nd

Pay ratio

Elias Kouchakji's Pay$2,885,280
Median Employee's Pay$177,952
Pay Ratio

16

to 1

In 2020, the annual total compensation of Elias Kouchakji was $2,885,280.

The annual total compensation of the median employee at FibroGen was $177,952.

The ratio of Elias Kouchakji's pay to the pay of median employee was therefore 16 to one.

Source: SEC filing on April 13, 2021.

Kouchakji's colleagues

We found seven more compensation records of executives who worked with Elias Kouchakji at FibroGen in 2020.

2020

Enrique Conterno

FibroGen

Chief Executive Officer

2020

Thane Wettig

FibroGen

Chief Commercial Officer

2020

Mark Eisner

FibroGen

Chief Medical Officer

2020

K Yu

FibroGen

Chief Medical Officer

2020

Pat Cotroneo

FibroGen

Chief Financial Officer

2020

Christine Chung

FibroGen

Senior Vice President, China Operations

2020

James Schoeneck

FibroGen

Chief Executive Officer

News

You may also like